BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 29173185)

  • 1. A Review on Melatonin's Effects in Cancer: Potential Mechanisms.
    Hanikoglu A; Kucuksayan E; Akduman RC; Ozben T
    Anticancer Agents Med Chem; 2018; 18(7):985-992. PubMed ID: 29173185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin and cancer: current knowledge and its application to oral cavity tumours.
    Cutando A; Aneiros-Fernández J; Aneiros-Cachaza J; Arias-Santiago S
    J Oral Pathol Med; 2011 Sep; 40(8):593-7. PubMed ID: 21284745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 Diabetes and Cancer.
    Wojcik M; Krawczyk M; Wojcik P; Cypryk K; Wozniak LA
    Curr Med Chem; 2017 Nov; 24(35):3829-3850. PubMed ID: 28721827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant properties of melatonin and its potential action in diseases.
    Karaaslan C; Suzen S
    Curr Top Med Chem; 2015; 15(9):894-903. PubMed ID: 25697560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revealing Melatonin's Mysteries: Receptors, Signaling Pathways, and Therapeutics Applications.
    Kulsoom K; Ali W; Saba Z; Hussain S; Zahra S; Irshad M; Ramzan MS
    Horm Metab Res; 2024 Jun; 56(6):405-418. PubMed ID: 38081221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic mechanisms involved in the anti-cancer effects of melatonin.
    Mediavilla MD; Sanchez-Barcelo EJ; Tan DX; Manchester L; Reiter RJ
    Curr Med Chem; 2010; 17(36):4462-81. PubMed ID: 21062257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth-inhibitory activity of melatonin on murine foregastric carcinoma cells in vitro and the underlying molecular mechanism.
    Xu L; Liu H; Zhang H; Wang RX; Song J; Zhou RX
    Anat Rec (Hoboken); 2013 Jun; 296(6):914-20. PubMed ID: 23564716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propanamide on murine Colon 38 cancer growth in vitro and in vivo.
    Winczyk K; Pawlikowski M; Lawnicka H; Kunert-Radek J; Spadoni G; Tarzia G; Karasek M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():50-4. PubMed ID: 12019352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of melatonin on the development of abdominal aortic aneurysm in a rat model.
    Tang L; Cong Z; Hao S; Li P; Huang H; Shen Y; Li K; Jing H
    J Surg Res; 2017 Mar; 209():266-278.e1. PubMed ID: 27392820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin: A Potential Antineoplastic Agent in Breast Cancer.
    Samanta S
    J Environ Pathol Toxicol Oncol; 2022; 41(4):55-84. PubMed ID: 36374962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia.
    Kilic U; Yilmaz B; Ugur M; Yüksel A; Reiter RJ; Hermann DM; Kilic E
    J Pineal Res; 2012 Mar; 52(2):228-35. PubMed ID: 21913972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential utility of melatonin in the treatment of childhood cancer.
    Chao YH; Wu KH; Yeh CM; Su SC; Reiter RJ; Yang SF
    J Cell Physiol; 2019 Nov; 234(11):19158-19166. PubMed ID: 30945299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory and antioxidant effect of melatonin on recovery from muscular trauma induced in rats.
    Ostjen CA; Rosa CGS; Hartmann RM; Schemitt EG; Colares JR; Marroni NP
    Exp Mol Pathol; 2019 Feb; 106():52-59. PubMed ID: 30521792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the use of melatonin overcome drug resistance in cancer chemotherapy?
    Asghari MH; Ghobadi E; Moloudizargari M; Fallah M; Abdollahi M
    Life Sci; 2018 Mar; 196():143-155. PubMed ID: 29374563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin and hypothalamic-pituitary-gonadal axis.
    Shi L; Li N; Bo L; Xu Z
    Curr Med Chem; 2013; 20(15):2017-31. PubMed ID: 23410151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockage of melatonin receptors impairs p53-mediated prevention of DNA damage accumulation.
    Santoro R; Mori F; Marani M; Grasso G; Cambria MA; Blandino G; Muti P; Strano S
    Carcinogenesis; 2013 May; 34(5):1051-61. PubMed ID: 23354312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy.
    Witt-Enderby PA; Radio NM; Doctor JS; Davis VL
    J Pineal Res; 2006 Nov; 41(4):297-305. PubMed ID: 17014686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin modulates tumor metabolism and mitigates metastasis.
    Reiter RJ; Sharma R; Tan DX; Huang G; de Almeida Chuffa LG; Anderson G
    Expert Rev Endocrinol Metab; 2023; 18(4):321-336. PubMed ID: 37466337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin: a potential intervention for hepatic steatosis.
    Sun H; Huang FF; Qu S
    Lipids Health Dis; 2015 Jul; 14():75. PubMed ID: 26199093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin and its ubiquitous anticancer effects.
    Bhattacharya S; Patel KK; Dehari D; Agrawal AK; Singh S
    Mol Cell Biochem; 2019 Dec; 462(1-2):133-155. PubMed ID: 31451998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.